A person wearing a light blue denim jacket, hoodie, and black pants walks a brown curly-haired dog on a leash along a leaf-covered path in a wooded area.

About Sooma

We believe good care should fit into real life. Sooma builds medical-grade tDCS (transcranial direct current stimulation) treatment for depression and chronic pain, made for use at home. Since 2013, we have worked with psychiatrists and brain scientists to make it safe and backed by evidence.

What we care about

High-quality care that is easy to access.

Relief from symptoms, without creating new ones.

Safe, effective treatment, with no fear of dependency.

A better quality of life every day, for everyone.

Our story

Sooma started in Helsinki, Finland, in 2013. We build our devices with psychiatrists and brain researchers, the same experts who have worked with us from day one.

Sooma tDCS launched in 2014 to treat major depressive disorder, known in the ICD-11 as depressive episode. In 2017, we added treatment for chronic pain, including fibromyalgia and nerve pain.

Every Sooma device is designed in Finland to the ISO 13485 quality standard. Sooma tDCS is a CE Class IIa medical device, certified under the EU Medical Device Regulation (MDR).

Today, more than 300 care and research institutions worldwide work with Sooma. Over 35,000 patients have used our treatment.